Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar taylja06 (< 20) Submitted: 8/7/2012 3:38:31 PM : Outperform Start Price: $0.99 ANTH Score: +1.74

Once their new anti-lupus drug (which is not stellar on its own but has solid anti-inflammatory effects) reaches Phase III testing a solid jump should help create more market volume and desire for the stock, especially with the recent common stock offering freeing up market movement.

Featured Broker Partners


Advertisement